<DOC>
	<DOCNO>NCT01681030</DOCNO>
	<brief_summary>This three-arm , randomize multicenter study evaluate safety effectiveness EVARREST™ Fibrin Sealant Patch control mild moderate vascular anastomosis suture line bleed cardiovascular surgery .</brief_summary>
	<brief_title>The Fibrin Pad Cardiovascular Study</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Subjects ≥18 year age , require elective urgent , open aortic surgical procedure utilize cardiopulmonary bypass ; Subjects must willing participate study provide write informed consent . Subjects know intolerance blood product one component study product unwilling receive blood product ; Exposure another investigational drug device clinical trial within 30 day prior surgery anticipated 30 day follow period surgery . Female subject pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>